Secondary Bacterial Pneumonias and Bloodstream Infections in Patients Hospitalized with COVID-19

Max W. Adelman, Divya Bhamidipati, Alfonso C. Hernandez‐Romieu, Ahmed Babiker, Michael H. Woodworth, Chad Robichaux, David J. Murphy, Sara C. Auld, Colleen S. Kraft, Jesse T. Jacob

2021Annals of the American Thoracic Society19 citationsDOI Open Access PDF

Abstract

Pneumonias and Bloodstream Infections in Patients Hospitalized with COVID-19To the Editor:Hospitalized patients, particularly those who are critically ill, are at risk for "secondary" infections (1, 2).Initial reports of patients hospitalized with coronavirus disease (COVID-19) indicate that 10-33% develop bacterial pneumonia (3, 4) and 2-6% develop bloodstream infection (BSI) (5, 6).Few studies have reported patient characteristics or the impact of intensive care unit (ICU) admission on secondary infections (3,(6)(7)(8).We conducted a descriptive study to identify the prevalence, microbiology, and outcomes of secondary pneumonias and BSIs in patients hospitalized with COVID-19.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Pneumonia2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusIntensive care medicineBacteremiaVirologyMicrobiologyAntibioticsInternal medicineInfectious disease (medical specialty)OutbreakBiologyDiseaseAntibiotic Use and ResistanceNosocomial Infections in ICUCOVID-19 Clinical Research Studies